Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Vaccination-infection interval determines cross-neutralization potency to SARS-CoV-2 Omicron after breakthrough infection by other variants

4 Mar 2022

Abstract excerpt

No abstract is available from the source.

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to COVID-19 Clinical Research Studies
Share to SARS-CoV-2 and COVID-19 Research
Share to vaccines and immunoinformatics approaches

Source

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Identifiers

PMID: 35261995
DOI: 10.1016/j.medj.2022.02.006

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 6 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Vaccination-infection interval determines cross-neutralization potency to SARS-CoV-2 Omicron after breakthrough infection by other variantsPMID 35261995Read ↗

Estimating serum cross-neutralizing responses to SARS-CoV-2 Omicron sub-lineages elicited by pre-Omicron or Omicron breakthrough infection with exposure interval compensation modelingSemantic proximity Read ↗

SARS-CoV-2 vaccination induces immunological T cell memory able to cross-recognize variants from Alpha to OmicronSemantic proximity Read ↗

Third SARS-CoV-2 Vaccination and Breakthrough Infections Enhance Humoral and Cellular Immunity Against Variants of ConcernSemantic proximity Read ↗

Incidence and risk factors of omicron variant SARS-CoV-2 breakthrough infection among vaccinated and boosted individualsSemantic proximity Read ↗

Antigenic sin of wild-type SARS-CoV-2 vaccine shapes poor cross-neutralization of BA.4/5/2.75 subvariants in BA.2 breakthrough infectionsSemantic proximity Read ↗

Antibody escape, the risk of serotype formation, and rapid immune waning: modeling the implications of SARS-CoV-2 immune evasionSemantic proximity Read ↗

B cell genomics behind cross-neutralization of SARS-CoV-2 variants and SARS-CoVSemantic proximity Read ↗

Broadly neutralizing antibodies overcome SARS-CoV-2 Omicron antigenic shiftSemantic proximity Read ↗

Broadly neutralizing antibodies overcome SARS-CoV-2 Omicron antigenic shiftSemantic proximity Read ↗

COVID-19 breakthrough infection after inactivated vaccine induced robust antibody responses and cross-neutralization of SARS-CoV-2 variants, but less immunity against omicronSemantic proximity Read ↗

Transmission event of SARS-CoV-2 Delta variant reveals multiple vaccine breakthrough infectionsSemantic proximity Read ↗

Multiple infections with Omicron variants increase breadth and potency of Omicron-specific neutralizing antibodiesSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.